Research
Hormonal
The presence of obesity-related complications (e.g., Type 2 Diabetes, Hypertension) significantly amplifies medical costs, with costs up to 5.2 times higher for those with multiple complications compared to obesity alone.
Having obesity-related complications like Type 2 Diabetes or Hypertension drastically increases medical costs (up to 5.2x). This underscores the importance of not just losing weight, but also managing these specific conditions to control overall healthcare spending.
GoodSupportsHIGH confidence
costs were up to 5.2-fold greater with obesity, T2DM, and hypertension.
Why this rating
Based on 7 studies reporting costs by complications.
Source
Costs of obesity, obesity-related complications, and weight loss in the United States: A systematic literature review
Alison M. Bjornson et al. · Journal of Managed Care & Specialty Pharmacy · 2025
DOI 10.18553/jmcp.2025.25051
systematic_reviewCited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Achieving a 5% weight loss over one year results in substantial direct medical cost savings for people with obesity, with savings increasing alongside higher obesity severity.Good
- Obesity severity (Class I, II, III) is directly correlated with increased direct medical costs, with Class III obesity costing up to 3.3 times more than normal weight individuals.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →